19·39)10·85 (3·81 to 18·98)–1·66 (−10·26 to 7·78)–22·54 (−28·68 to −15·43)*331·91 (114·69 to 595·93)306·32 (105·80 to 541·94)–7·71 (−17·35 to 2·77)–25·19 (−32·55 to −16·79)*··Prostate cancer15·29 (11·00 to 19·90)16·68 (11·72 to 22·10)9·09 (2·16 to 18·00)*–19·29 (−24·05 to −12·77)*257·95 (186·43 to 331·39)268·27 (190·32 to 355·74)4·00 (−3·76 to 12·92)–21·25 (−26·88 to −14·50)*··Kidney cancer20·10 (13·46 to 26·02)22·07 (14·53 to 29·44)9·79 (1·71 to 18·14)*–16·07 (−21·91 to −9·92)*464·77 (311·24 to 604·80)480·06 (316·13 to 639·24)3·29 (−5·41 to 12·59)–19·84 (−26·34 to −12·84)*··Bladder cancer44·33 (33·18 to 55·10)49·84 (36·98 to 63·01)12·42 (6·43 to 18·18)*–15·76 (−20·05 to −11·55)*820·50 (616·52 to 1016·68)867·04 (639·82 to 1098·93)5·67 (−0·75 to 11·94)–19·01 (−23·71 to −14·36)*··Acute lymphoid leukaemia2·45 (1·19 to 3·88)2·65 (1·26 to 4·39)8·51 (−1·79 to 18·19)–14·18 (−21·95 to −6·75)*74·37 (35·76 to 121·34)77·25 (35·75 to 131·34)3·87 (−8·05 to 15·59)–16·04 (−25·20 to −6·72)*··Chronic lymphoid leukaemia4·13 (2·06 to 6·30)4·32 (2·09 to 6·76)4·69 (−3·63 to 13·22)–21·24 (−27·22 to −15·09)*81·77 (41·39 to 125·41)81·18 (39·93 to 126·38)–0·73 (−9·78 to 8·35)–23·72 (−30·52 to −17·08)*··Acute myeloid leukaemia7·27 (3·54 to 11·03)8·00 (3·82 to 12·46)10·07 (2·74 to 16·47)*–14·79 (−20·27 to −10·13)*174·17 (88·65 to 265·91)182·46 (89·93 to 285·57)4·76 (−3·79 to 12·31)–17·20 (−23·71 to −11·49)*··Chronic myeloid leukaemia2·27 (1·10 to 3·48)1·92 (0·89 to 3·02)–15·62 (−22·48 to −8·88)*–34·65 (−39·76 to −29·68)*56·81 (27·53 to 88·46)45·30 (21·19 to 72·34)–20·26 (−27·97 to −13·34)*–36·45 (−42·56 to
